NEIRG Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
NEIRG Wealth Management's BMY Position: Q3 2023 in Review
NEIRG Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,747 shares — an estimated $304K sold.
NEIRG Wealth Management first reported a position in BMY in Q4 2021 and held it in 7 quarters. The position peaked at $343K in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- NEIRG Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- NEIRG Wealth Management sold 4,747 Bristol-Myers Squibb shares in Q3 2023, an estimated $304K.
- NEIRG Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 7 quarters.
- NEIRG Wealth Management's Bristol-Myers Squibb position peaked at $343K in Q2 2022.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on NEIRG Wealth Management's 13F filing for Q3 2023.